HEOR

News

England poised to roll out drug for rare eye disease LHON

Patients in England with rare eye disorder LHON will finally get access to a Chiesi drug that has been available in the rest of the UK for years.

News

New medicines review process under NHS 10-Year Plan emerges

More details have emerged of a UK plan for new medicines to get simultaneous decisions from the MHRA and NICE on their use by the NHS.

News

NICE CEO to step down by year-end

Sam Roberts is stepping down from the role of NICE CEO to support her children through a difficult time, and a search for her replacement is underway.

News

NICE relents and backs Kisqali for wide use in breast cancer

Novartis' breast cancer therapy Kisqali has been cleared for NHS use in early breast cancer, an indication driving blockbuster sales of the drug.

News

Four AIs for spinal fractures can be used by NHS, says NICE

AIs that detect spinal fractures during routine CT scans could help the NHS reduce hip fractures and other costly complications, says NICE.

News

New cystic fibrosis triple from Vertex backed for NHS use

Vertex has won NICE's backing for a new cystic fibrosis therapy, Alyftrek, that could be an option for 89% of NHS patients with the genetic disorder.

England poised to roll out drug for rare eye disease LHON

New medicines review process under NHS 10-Year Plan emerges

NICE CEO to step down by year-end

NICE relents and backs Kisqali for wide use in breast cancer

Four AIs for spinal fractures can be used by NHS, says NICE

New cystic fibrosis triple from Vertex backed for NHS use

LSX2026: On a therapeutic vision for ocular disease, with Al...

Using AI-driven synthetic personas to take your insights fur...

HEOR

Editor's Picks